Computational studies suggest a set of genes that regulate immune response help determine robustness and durability of neutralizing antibodies to virus
The UC Davis Children’s Hospital Transport Team specializes in bringing an advanced level of care to infants and children at surrounding community hospitals, where appropriate resources may not be available.
The Psychedelics and Health Research Initiative at UC San Diego has received a $1.3 million grant from the Steven and Alexandra Cohen Foundation to fund a clinical trial investigating the therapeutic potential of psilocybin in treating phantom limb pain.
COVID-19 is far from beaten. Vaccines may not be the ultimate panacea to haul us out of the pandemic crisis. In the future, will outbreaks of SARS-CoV-2, the virus that causes COVID-19, arrive in waves every winter? Might COVID-19 never go away? Experts at the University of California, Riverside, weigh…
The latest edition of the UC Davis Children’s Hospital Annual Report is now available. The publication covers2019-2020, an historic year that included the coronavirus and the separation of craniopagus twins.
Surgical resident Jennifer Geiger has received a $30,000 research grant to devise a new curriculum that teaches residents how to better communicate with patients facing end-of-life decisions.
UC Davis Comprehensive Cancer Center Director Primo “Lucky” Lara, Jr. helped author a clinical trial testing the best treatment for metastatic papillary kidney cancer. The promising results are published in The Lancet.
A new study led by researchers at the UCLA Jonsson Comprehensive Cancer Center helps identify which patients with prostate cancer will benefit most from the use of prostate-specific membrane antigen PET imaging, PSMA PET, a novel imaging technique that recently was approved by the U.S. Food and Drug Administration.
Health Media Contacts
Find the best contact for health-related media inquiries.
